Trial Profile
Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary)
- Indications Mixed incontinence
- Focus Therapeutic Use
- 27 Aug 2013 New trial record